Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 500 ms (Expand Search), 50 mg (Expand Search), 50 mm (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 500 ms (Expand Search), 50 mg (Expand Search), 50 mm (Expand Search)
-
12141
-
12142
-
12143
-
12144
Silencing GRK2 and GRK3 attenuate C3aR desensitization but GRK5 and GRK6 do not.
Published 2013“…<p>(A) shRNA control, (B) GRK2, (C) GRK3, (D) GRK5 and (E) GRK6 KD cells were loaded with Indo-1 (1 µM), stimulated with C3a (100 nM) for 5 min and intracellular Ca<sup>2+</sup> mobilization was determined (black solid lines). …”
-
12145
-
12146
-
12147
-
12148
Young aphasia case study: Source localisation results of the context effect (constrained vs unconstrained naming) in A. and control
Published 2022“…Power was thresholded at ±1.5. Corresponding Cohen’s d maps (bottom two rows) for control (third row) and A. …”
-
12149
-
12150
-
12151
-
12152
-
12153
-
12154
-
12155
-
12156
Mendelian randomization results with COVID-19.
Published 2022“…The bottom section shows results consistent with five blood markers being significantly causally associated with an increased risk for the need of respiratory support/death due to COVID-19 and eight blood markers causally associated with a decreased risk for the need of respiratory support/death due to COVID-19, as well as one protein decreasing risk for the need of respiratory support/death due to COVID-19. …”
-
12157
-
12158
Data_Sheet_1_A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.PDF
Published 2023“…/mL (IQR 285.4) (p = 0.05); serum month 24: 6.7 pg/mL (IQR 4.7) (p < 0.01); serum month 60: 7.2 pg/mL (IQR 4.7) (p < 0.01)], compared to baseline [CSF: 1014 pg/mL (IQR 2832.5); serum 8.6 pg/mL (IQR 17.4)].</p>Conclusion<p>In this real-world mono-center population, we observed a progression-free survival of 69%, cumulative NEDA-3 of 33%, and reduced NfL levels, over a five-year follow-up. …”
-
12159
-
12160